SC: Removal of the Two-finger Test From the Medical Curriculum, and More

Hi Renukaprasad A R, Top Stories of the Day: SC: Removal of the Two-finger Test From the Indian Medical Curriculum NFHS-5: Less Than 50% of Full ANC Coverage in the Indian Districts Singapore: No New Curbs in the Recent COVID Wave AIIMS, India: Neuro App to the Aid of Stroke Patients in Rural Areas Ultra-potent Antibodies Against Omicron Variants Webinar: Thrombocytopenia in Children Healthcare headlines that matter, brought to you every day by Docplexus Health Minute! Watch News   Docplexus is one of the world's largest online communities Pune - 411045, India Unsubscribe from this mailing list. *|LIST:DESCRIPTION|* *|LIST:ADDRESS|* *|REWARDS_TEXT|*

Postoperative DED: The Other Outcome of Cataract Surgery

Docplexus is one of the world's largest online communities

Hi Renukaprasad A R, Cataract surgery accounts for millions of ocular surgeries performed globally. While it offers patient benefits in terms of a high success rate, it does have several potential complications. Dry eye disease (DED) is the most typical complication and needs to be addressed promptly. Artificial tear products (ATPs) are the gold standard for postoperative DED management. ATP-containing polyethylene glycol (PEG), propylene glycol (PG), and hyaluronic acid (HA) provide multiple benefits to these patients. Read this article for more information on how the PEG-PG-HA solution relieves DED symptoms and improves tear film quality. Highlights: DED is the most frequent complication post-cataract surgery. DED is associated with some pre-, intra-, and post-risk factors. Presurgical evaluation of the ocular surface can decrease the incidence. Using HPG and HA eye drops for treating post-cataract DED provides favorable results. Read More If you don't want to receive these emails in the future, please unsubscribe.

Apps for Diabetes Management - The SMART Healthcare

Docplexus is one of the world's largest online communities

Hi Renukaprasad A R, Diabetes is a challenging and increasingly expensive health problem of the twenty-first century. A standardized medical and behavioral treatment protocol is essential to improve the quality of life of diabetes patients and prevent premature morbidity and mortality. Personalized diabetes care has been revolutionized by the rapid progression of artificial intelligence, machine learning, big data analytics, and other advances in mobile computing.1 Diabetes applications (apps) support patients in safely reaching their glycemic targets, potentially reducing the need for acute care.2 Watch Dr. Unnikrishnan A.G. sharing the importance of mobile apps in diabetes management. Highlights - Glucometer offerings Key to an effective diabetic care Mobile apps for diabetic management References - Kebede MM et al., Frontiers in Endocrinology. 2019 Mar 1;10:135. Salari R et al., Journal of Diabetes & Metabolic Disorders. 2019 Dec;18(2):333-40. Click to Watch If you don't want to receive these emails in the future, please unsubscribe.

How Does Eye Gel Residence Time Affect Tear Film Thickness?

Docplexus is one of the world's largest online communities

Hi Renukaprasad A R, What are your views on eye gels with a higher residence time on the ocular surface? Dry eye disease (DED) is a highly prevalent ocular surface disorder with a complex pathophysiology. The application of topical lubricants is the only standard therapy for treating DED. However, the efficacy of lubricants depends upon their formulation and the residence time on the ocular surface. Here is an Infographic that illustrates the influence of three different formulations of lubricants: trehalose 3% + hyaluronic acid 0.15%; hyaluronic acid 0.2%; and polyethylene glycol 0.4% + propylene glycol 0.3% on the tear film thickness. Highlights: Introduction and composition of the tear film Pathophysiology and etiology of DED Strategies for DED therapy and problems associated with therapy Effect of different lubricants on tear film thickness View Infographic If you don't want to receive these emails in the future, please unsubscribe.

Coming Up This Week: Anti-HER2 Therapy in Breast Cancer & More!

Hi Renukaprasad A R, This week, we bring you exclusive episodes of MasterSeries, OncoTalks, and more. Join the experts as they enlighten us on the recent updates and trends in the field of medicine. Don't miss out on this week's exclusive knowledge-packed sessions! STAY TUNED!!

Anti-HER2 Therapy in Breast Cancer About 15-20% of breast cancers overexpress human epidermal growth factor receptor 2 (HER2), which makes it an excellent target for treating HER2-amplified breast cancer. However, resistance to anti-HER2 treatment in advanced stages of cancer remains a challenge. Researchers have developed several anti-HER2 drugs in the past few years to overcome this obstacle. For more insights on the latest developments in anti-HER2 therapy for breast cancer, join the proficient oncologist Dr. Uma Dangi in an exclusive webinar on 31st October at 6:00 PM IST. View Webinar Details

Coming Up Next

MasterSeries: Thrombocytopenia in Children Immune thrombocytopenia, also known as idiopathic or immune thrombocytopenic purpura, is an acquired bleeding diathesis that results from premature platelet destruction, reduced platelet production, or a combination of both. Among infective causes, viral infections like dengue are generally the commonest ones. Other non-dengue infections include fungal and bacterial infections (gram-negative), enteric fever, malaria, and malignancies. To get more insights, join Dr. Emine Rahiman for an exclusive MasterSeries session "Thrombocytopenia in Children" on 2nd November 2022, at 3:00 PM IST. Click to Know More

OncoTalks: Paradigm Shift in Breast Cancer Surgery Breast cancer is a clinically and pathologically heterogeneous group of pathologic entities with different biological and clinical behaviors. Breast cancer surgery has evolved tremendously over the years, from the conventional radical mastectomy to the recent breast-conserving surgery.   Gain deeper insights into "Paradigm Shift in Breast Cancer Surgery" in an exclusive OncoTalks session by the expert Dr. Sridevi Murali Nanavati, on 3rd November 2022, 6 PM IST onwards. Add to Your Calendar

Other Upcoming Webinars which might interest You!

Oct 31, 3:00 PM onwards What a Pediatrician/Physician Needs to Know About Liver Transplant? Nov 1, 3:00 PM onwards Transplant and Pulmonary Hypertension

Nov 1, 6:00 PM onwards Deep Brain Stimulation in Parkinson's Disease Nov 2, 6:00 PM onwards Primary Hypospadias

Nov 3, 3:00 PM onwards Sudden Deaths: Legal Aspects Nov 4, 3:00 PM onwards Oral Mucositis: An Urgent and Unmet Need of Cancer Patients

Nov 4, 6:00 PM onwards Overlap Syndromes and Management Nov 5, 5:00 PM onwards Management of Early and Advanced Tongue Cancers

Docplexus is one of the world's largest online communities Pune - 411045, India info@docplexus.co.in   |  +91 98500 36954 Change email preference | Unsubscribe